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An arginine-rich RNA-binding motif (ARM) found at the N-proximal region of Brome mosaic virus (BMV) coat protein (CP)
adopts a-helical conformation and shares homology with CPs of plant and insect RNA viruses, HIV-Rev and Tat proteins,
bacterial antiterminators, and ribosomal splicing factors. The ARM of BMV CP, consisting of amino acids 9 through 21 with
six arginine residues, is essential for RNA binding and subsequent packaging. In this study analysis of the a-helical contents
of wild-type and mutant peptides by circular dichroism spectra identified protein determinants required for such conforma-
tion. Electrophoretic mobility-shift assays between viral RNA and BMV CP peptides with either proline or alanine substitu-
tions revealed that the interaction is nonspecific. Expression in vivo of mature full-length BMV CP subunits, having the same
substitutions for each arginine within the ARM, derived from biologically active clones was found to be competent to
assemble into infectious virions and cause visible symptom phenotypes in whole plants. However, analysis of virion progeny
RNA profiles of CP variants and subsequent in vitro reassembly assays between mutant CP and four BMV RNAs unveiled the
ability of arginine residues at positions 10, 13, or 14 of the ARM to confer selective packaging of BMV RNA4. Thus, BMV CP
contains determinants that specifically interact with RNA4 to ensure selective packaging. © 2000 Academic Press
Key Words: arginine-rich motif; a-helical conformation; packaging; RNA-coat protein interactions; Brome mosaic virus.
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iINTRODUCTION
In eukaryotic cells RNA-protein interactions are inti-
mately involved in mediating several regulatory pro-
cesses such as pre-mRNA splicing, protein biosynthesis
(Burd and Dreyfuss, 1994), virus replication, and infec-
tious virion assembly (Schlensinger et al., 1994; Fox et
al., 1994). Among nine families of RNA-binding proteins
(Mattaj, 1993), those containing an arginine-rich motif
(ARM) are widely found in bacterial antiterminators,
splicing factors, ribosomal proteins, human immunodefi-
ciency (HIV) Tat and Rev proteins, and bovine immuno-
deficiency virus (BIV) Tat protein and coat proteins of
RNA viruses infecting plants and insects (Tan and
Frankel, 1995; Rao and Grantham, 1996). In order to
establish a successful infection by a given ssRNA virus,
its genome must be protected from nuclease degrada-
tion. This is achieved by packaging with the virus-en-
coded coat protein (CP). Since viral RNA and CP sub-
units are localized within the same compartment of the
cell (Matthews, 1991), cellular tRNA, mRNAs, or rRNAs
could potentially be copackaged with viral genomic
RNAs. However, specific sequence- and/or structure-
dependent interactions between CP and viral RNA are
envisioned to ensure that the majority of the virionsa
s
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207contain exclusively viral RNA (Cuillel et al., 1983; Osman
et al., 1998).
The Bromoviridae are a family of icosahedral, multi-
partite, single-stranded, positive-sense RNA viruses of
plants (Ahlquist, 1994). The genome of Brome mosaic
virus (BMV) is divided among three RNA components.
Monocistronic RNAs 1 and 2 encode nonstructural pro-
teins required for viral replication (Kao et al., 1992) while
discistronic RNA3 encodes the viral movement protein
(MP) and capsid protein (CP). Although MP is directly
translated from the genomic RNA3, CP is translated from
a subgenomic RNA (RNA4) transcribed by internal initi-
ation on progeny minus RNA3 (Miller et al., 1985). BMV
enomic RNAs 1 and 2 can replicate independent of
NA3 in protoplasts (French et al., 1986; Rao and Hall,
990); however, both MP and encapsidation-competent
P are required to mediate cell-to-cell and long-distance
pread in susceptible hosts (De Jong and Ahlquist, 1991;
ao and Grantham, 1995; Schmitz and Rao, 1996).
Bromoviruses have provided valuable systems for
tudying virus structure and replication. The three
enomic RNAs and a single subgenomic RNA4 of bro-
oviruses are packaged into three separate particles of
dentical size and morphology: RNAs 1 and 2 are pack-
ged separately while RNAs 3 and 4 are copackaged
nto a single particle (Fox et al., 1994). The involvement of
single CP in discriminating each of the four RNA
pecies and packaging into three individual particles
0042-6822/00 $35.00
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208 CHOI AND RAOsuggests that assembly of viral RNA is tightly regulated.
BMV virions, with T 5 3 symmetry, are assembled from
80 identical subunits of a single CP (Speir et al., 1995).
he N-proximal region of BMV CP containing 25 amino
cids is highly basic due to the presence of a conserved
RM characteristic of RNA binding proteins (Fig. 1).
ased on NMR studies Vriend et al. (1986) suggested
hat the N-terminal basic arm of another bromovirus,
owpea chlorotic mottle virus (CCMV) CP encompassing
he ARM is very mobile and in random coil conformation
n the absence of RNA. This flexibility could enhance the
hance of arginine and lysine side chains to meet with
he phosphate groups in the RNA; upon binding, the
ositive arginine and lysine residues and negative phos-
hate groups interact and the basic arm rolls up into a
igid a-helix (Vriend et al., 1986). Additional circular di-
chroism studies showed that peptides of BMV and
CCMV CP with ARM exhibit a-helical conformation (Tan
and Frankel, 1995) and such a-helical region is situated
between residues 9 and 19 (van der Graaf and Heminga,
1991). Previous mutational analysis of the N-terminal
basic arm revealed that CP variants lacking the first 7, but
not 19, are infectious and direct RNA-containing virion
assembly in vivo (Rao and Grantham, 1995, 1996; Sacher
and Ahlquist, 1989). Our recent in vivo analysis of an
additional BMV CP variant precisely lacking the N-termi-
nal ARM located between residues 9 and 19 revealed
that this region contains determinants for packaging of
FIG. 1. (A) Schematic representation of a-helices predicted for the
irst 25 N-terminal amino acids of BMV CP by the methods of Chou and
asman (1978) and Garnier et al. (1978). The hatched region indicates
he predicted a-helices. (B) A helical wheel presentation of 7 through
25 N-terminal amino acids of BMV CP showing the presence of posi-
tively charged arginine residues to one side of the wheel. Charged
amino acids are indicated by the charge and hydrophobic amino acids
are boxed.RNA4 (Choi et al., 2000). As an extension to these ob-
servations, in this study the importance of the predictedN-terminal a-helical conformation of BMV CP in RNA
binding was examined. The results show that a N-termi-
nal a-helical conformation is not crucial for RNA binding.
n vivo characterization of several biologically active
MV CP variant sequences identified amino acid deter-
inants within the N-terminal ARM that specifically in-
eract with subgenomic RNA4 and direct its packaging
nto mature virions.
RESULTS
a-Helical propensities of wild-type and mutant
peptides of ARM
ARMs enable a variety of RNA-binding proteins to
recognize specific regions in RNA when the peptide is in
a-helical form. Previous CD spectroscopy studies with
HIV-Rev and BMV CP wt peptides encompassing respec-
tive ARMs have been shown to adopt a-helical confor-
ation (Tan and Frankel, 1995). Before designing muta-
ions to precisely identify crucial amino acid residues
ithin the BMV CP ARM required for a-helical conforma-
ion, the primary structure and the potential secondary
tructure of the first 25 amino acids of BMV CP were
xamined. Application of the empirical secondary struc-
ure algorithm of Chou and Fasman (1978) predicts that
n a-helix exists between amino acids 19 and 23 while
he theoretical algorithm of Garnier et al. (1978) predicts
hat an a-helix begins at amino acid 18 (Fig. 1A). Since a
eptide encoding the ARM of BMV CP (amino acids
–25) has been shown to adopt a-helix conformation
(Tan and Frankel, 1995), a helical wheel diagram of this
region was constructed (Fig. 1B). The predicted structure
revealed the presence of positively charged arginine
residues on one side of the helical wheel (Fig. 1B). To
examine whether the amino acids of the predicted a-he-
lical region can adopt a-helical conformation and its
requirement for RNA-binding activity in vitro and in vivo,
we synthesized a wt and a set of mutant peptides of 19
amino acids in length (N-terminal residues 7–25; Table 1)
and measured their helicities by CD spectroscopy (Fig.
2A; Table 1). Two mutant peptides, 10P and 18P, con-
tained proline substitutions (expected to break the a-he-
ix) for respective arginines while another peptide, 10A,
ontained an alanine for arginine (Table 1). Three of the
our peptides, wt, 10P, and 10A, showed a significant
a-helical character ranging from 14 to 25% (Fig. 2A; Table
1). By contrast, mutant peptide 18P significantly abol-
ished a-helix formation (5%; Fig. 2A; Table 1). Since in
bromovirus CP a helical region is envisioned to exist
between N-terminal residues 9 and 17 (van der Graaf
and Hemminga, 1991), we anticipated that a proline sub-
stitution at position 10P would also abolish the a-helix.
However, this was not the case (Fig. 2A, Table 1). One
possible explanation for the maintenance of a-helix for-
mation for peptide 10P is that the proline is too close to
the N-terminus of the synthetic peptide. Therefore an
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209SELECTIVE PACKAGING OF BMV RNA4additional peptide, referred to as 10P* of 17 amino acids
in length (N-terminal residues 3–19; Table 1), was syn-
thesized by positioning 10P in the center of the peptide.
A similar-size peptide with wt sequence (Wt*; Table 1)
was also synthesized as a control. CD spectral analysis
of these two peptides did not reveal any significant
difference in a-helical contents of Wt* and 10P* peptides
(Table 1).
N-terminal a-helix is not required for RNA binding in
vitro
To examine whether a-helix conformation is crucial for
NA binding, as observed for other proteins with ARMs
Burd and Dreyfuss, 1994; Tan and Frankel, 1995), the
nteractions between wt and mutant peptides (Table 1)
nd each of the three genomic and a single subgenomic
NA4 BMV were analyzed by gel-shift assays. Peptides
f wt and 10P bound to each RNA tightly and the complex
as completely shifted (Fig. 2B; Table 1). No correlation
etween a-helix conformation and RNA binding was ob-
served since mutant peptide 18P, which abolished a-he-
lix conformation (Fig. 2B; Table 1), also bound each RNA
and complete shifting of the complex required only two-
fold higher peptide concentration (Table 1). The specific-
ity of each synthetic peptide was also tested by compet-
itive binding using homologous and heterologous RNAs
such as tobacco mosaic virus, cucumber mosaic virus,
and Xenopus RNA. Each heterologous RNA effectively
competed and bound to wt and mutant peptides (data not
shown). A previous study has found that heparin in-
creases the specificity of interaction between a given
RNA and a protein (Tanguay and Gallie, 1996). Although
all our binding reactions contain 50 mg heparin, as ob-
served by Duggal and Hall (1993), our in vitro binding
T
a-Helical Content of Wild-Type and N-Te
Peptidea Sequenceb
a-Helical
content (%)c
Wt (7–25) KMTRAQRRAAARRNRWTAR 25
9P KMPRAQRRAAARRNRWTAR 23
10P KMTPAQRRAAARRNRWTAR 24
10A KMTAAQRRAAARRNRWTAR 14
18P KMTRAQRRAAAPRNRWTAR 5
Wt* (3–19) SGTGKMTRAQRRAAARR 21
10P SGTGKMTPAQRRAAARR 20
a Peptides were synthesized and characterized according to Chen an
he BMV CP.
b In mutant peptides, the altered amino acid is indicated by boldfac
c a-Helical contents were determined according to Chen et al. (1974
d ND, not determined.assays indicate that the interaction between BMV CP
and heterologous RNAs is nonspecific (Fig. 2B).
P
wBMV CP variants selectively effect RNA4 packaging
in vivo
In bromoviruses, the N-terminal basic arm is not visi-
ble in the electron density map and it is predicted to be
internal to the virion (Speir et al., 1995). However, several
BMV CP variants having precise deletions in the
N-terminal basic arm exhibited altered biological prop-
erties when tested in Chenopodium quinoa (Rao and
Grantham, 1995, 1996). Although we did not observe a
correlation between a-helical conformation of a peptide
nd RNA binding (Fig. 2A; Table 1), a possibility exists
hat the effect of an engineered change in a N-terminal
a-helix region on RNA binding would be more obvious in
vivo when present on a full-length CP. Whole plant infec-
tion by BMV requires functional movement protein and
encapsidation-competent CP (De Jong and Ahlquist,
1991; Rao and Grantham, 1995; Schmitz and Rao, 1996).
Therefore, the most effective way of testing the role of
N-terminal a-helix on RNA binding and subsequent virion
ssembly is to directly examine the infectivity of BMV CP
ariants bearing N-terminal proline mutations used for
D spectral analysis. Thus, a set of four CP variants
B3/10P, B3/13P, B3/14P, and B3/18P; Fig. 3A), each con-
aining a proline substitution for a desired arginine res-
due located within the ARM, was constructed in a bio-
ogically active clone of BMV RNA3 (B3; Fig. 3A). Since
MV RNA replication is independent of RNA3 (French et
l., 1986; Rao and Hall, 1990), transfection of barley
rotoplasts with each B3 variant resulted in efficient
ynthesis of progeny (1) and (2) RNA (Figs. 3B and 3C)
nd CP (Fig. 3D) similar to the inoculum containing wt B3.
To examine the effect of each mutation on whole plant
nfection, C. quinoa plants were inoculated with a mix-
ure containing wt transcripts of B1, B2, and either B3/
Mutant Peptides of BMV Coat Protein
K d values
NA1 RNA2 RNA3 RNA4 Xenopus RNA
2.6 12.6 12.6 25.6 12.6
5.6 25.6 25.6 51.2 ND
5.6 25.6 25.6 51.2 12.6
5.6 25.6 25.6 51.2 12.6
5.6 25.6 25.6 51.2 25.6
NDd ND ND ND ND
ND ND ND ND ND
el (1994). Numbers in parentheses refer to amino acid positions within
nderlined.ABLE 1
rminal
R
1
2
2
2
2
d Frank
e and u10, B3/P13, B3/P14, or B3/P18. All four variant inocula
ere infectious and induced local lesions on a time
he indi
210 CHOI AND RAOscale similar to that of control inoculations containing wt
B3. However, among four variants, only B3/18P induced
chlorotic local lesions and systemic spread characteris-
tic of wt while the other three variants induced necrotic
local lesions and failed to move systemically even after 3
weeks postinoculation. Northern blot analysis of total
RNA from each symptomatic plant revealed an RNA
profile characteristic of BMV (data not shown). These
observations were consistently reproduced in at least
three independent experiments. Since induction of local
lesions by BMV requires synthesis of encapsidation-
competent CP (Rao and Grantham, 1995, 1996; Schmitz
and Rao, 1996), it is surmised that each CP translated
from the respective RNA4 of four proline variants must
have been competent to assemble into virions, resulting
in efficient cell-to-cell spread causing local lesion induc-
FIG. 2. (A) Circular dichroism of wild-type and mutant synthetic pept
Table 1. Peptides were synthesized according to Tan and Frankel (199
Band-shift assays. An autoradiograph of agarose gel showing band-
full-length BMV genomic RNAs and a single subgenomic RNA4 and t
peptides at twofold increments used in each reaction.tion. To substantiate this assumption, virions were puri-
fied from symptomatic leaves, negatively stained, andexamined under the electron microscope. All prepara-
tions contained icosahedral virions indistinguishable
from those of wt BMV. Examples are shown in Fig. 3E.
To examine the nucleic acid profile of purified virions,
RNA was isolated and examined by agarose gel electro-
phoresis. As expected RNA isolated from wt virions con-
tained three genomic and a single subgenomic RNA4
(Fig. 3F). Interestingly, RNA isolated from virions assem-
bled from CPs of 10P, 13P, and 14P variants contained
only three genomic RNAs while subgenomic RNA4 was
not detected (Fig. 3F). By contrast the virion RNA profile
of the 18P variant resembled that of wt control (Fig. 3F).
These RNA profiles were consistently reproduced from
at least four independent purified virion preparations
obtained from respective symptomatic leaves of C. qui-
noa. Northern blot analysis of virion RNA with riboprobes
BMV CP. Amino acid sequence of each synthetic peptide is shown in
ble mimina at 208 and 222 nm are indicative of a-helix formation. (B)
says to demonstrate the binding activity between each of the three
cated synthetic peptide. The numbers indicate concentration (mM) ofides of
5). Dou
shift asspecific for RNA3 and RNA4 revealed that detection of
trace amounts (.5%) of RNA4 in virions of 10P, 13P, and
o
t
p
p
m arose g
v eft.
211SELECTIVE PACKAGING OF BMV RNA414P variants required prolonged exposures of the blot
whereas the profile for variant 18P was similar to that of
wt (Fig. 3G).
In vitro reassembly assays confirm RNA4 packaging
defects
Bromoviruses can readily be dissociated into CP and
RNA and reassembled in vitro to form virions indistin-
guishable from those isolated from infected plants (Fox
et al., 1994). Two sets of conditions are normally used to
assemble bromoviruses in vitro. Under high salt and
acidic pH (1 M NaCl and pH 4.8), both empty and RNA-
containing virions are assembled, although no empty
FIG. 3. (A) The structure of wild-type (wt) BMV RNA3 (B3) is shown, wi
gene (3a) as an open box. The stippled box represents the CP gene. (B)
a proline mutation is indicated by an underline. The nomenclature used t
by a proline (P) substitution for an arginine (R) at position 10 in the wt B3 c
blots showing the accumulation of progeny RNAs in barley protoplasts tra
blots were hybridized with 32P-labeled RNA probes complementary to the h
r (2) sense. The positions of BMV RNAs are shown to the left. (D) Western
o BMV CP antiserum and detected using a chemiluminescent kit (Amersh
roline variants. Virions were isolated from symptomatic leaves of Cheno
roline variant. Purified virion preparations were negatively stained with ura
icroscope. Bar 5 100 nm. (F) Virion RNA profiles of B3 proline variants. Ag
ariant. The positions of the four wild-type BMV RNAs are shown to the lparticles are found in vivo (Zhao et al., 1995). By contrast,
under low salt and near neutral pH (50 mM NaCl and pH7.2), only RNA-containing virions are assembled. Since
the latter conditions reflect the in vivo situation, all our in
vitro reassembly assays were performed under low salt
and near neutral pH. Furthermore, under these condi-
tions, unlike in vitro binding assays (Fig. 2B; Table 1), the
interaction between BMV CP and RNA was found to be
highly specific, since heterologous RNA was not pack-
aged by BMV CP (Table 2; Choi et al., 2000). Thus, each
proline variant CP was isolated from purified virions
obtained from symptomatic leaves and allowed to reas-
semble in the presence of either individual or desired
combinations of wt BMV RNA transcripts. Results of
these experiments are shown in Fig. 4A and summarized
oding sequences represented as single lines and the movement protein
nal analysis of ARM of BMV CP. In each B3 variant clone the location of
nate each variant clone is exemplified by B3/10P, which is characterized
and C) Replication of B3 proline variants in barley protoplasts. Northern
d with in vitro transcripts of wt RNAs 1 and 2 and the indicated B3. The
gous 39 region present on each of the four BMV RNAs to detect either (1)
alysis of B3 proline variants. The blot was probed with antibodies specific
e position of BMV CP is shown to the left. (E) Electron micrographs of B3
quinoa infected with wt B1 and B2 and either wt B3 or the indicated B3
tate and photographed when viewed under Hitachi transmission electron
el electrophoresis of RNA isolated from purified virions of each B3 prolineth nonc
Mutatio
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lone. (B
nsfecte
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blot an
am). Th
podium
nyl acein Table 2. As observed in vivo, wt CP and CP of proline
variant 18P readily assembled into virions characteristic
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212 CHOI AND RAOof bromoviruses when transcripts of BMV RNAs 1 1 2,
1 4, 3, or 4 were provided in the reaction (Fig. 4A).
imilarly, CP of variant 10P was also competent to as-
emble into virions indistinguishable from wt BMV with
ranscripts of either 1 1 2, 3 1 4, or 3 alone but not when
ranscripts of RNA4 are provided as substrates (Fig. 4A).
imilar selective packaging defects for RNA4 transcripts
ere observed for CPs of 13P and 14P variants (Table 2).
To analyze the nucleic acid profile of in vitro reassem-
led virions, RNA was isolated, subjected to Northern
lot analysis, and hybridized with riboprobes. Data pre-
ented in Fig. 4B demonstrate that each in vitro reas-
embled virus preparation contained the expected RNA
rofile. For example, consistent with RNA profiles ob-
ained from purified virion recovered from symptomatic
eaves (Fig. 3F), CPs of wt and 18P variants efficiently
ackaged RNA4 while that of variant 10P was specifically
efective in packaging RNA4 when the transcript was
upplied either independently or in combination with
NA3 (Fig. 4B).
-terminal proline mutations specifically affect
ackaging but not RNA binding
Since formation of bromovirus virions and their stabil-
ty are dependent on RNA-protein interactions (Fox et al.,
994), one possible reason for the absence of virion
ssembly in vivo and in vitro for variants 10P, 13P, and
4P could have been due to lack of interaction between
NA and each mutant CP. To verify this possibility, in vitro
eassembled RNA-protein complexes formed between
ach mutant CP and radiolabeled RNA4 transcripts, fol-
owing Centricon purification steps, were divided into
wo aliquots. One aliquot was treated with RNase while
he other was left as untreated control and analyzed by
T
In Vitro Rea
Coat proteinb 1 1 2 3 1 4 3
Wt V V V V
B3/10P V V V RN
B3/13P V V V RN
B3/14P V V V RN
B3/18P V V V V
a In vitro reassembly assays were performed according to Zhao et
ribonucleoprotein complex), no virion formation but nuclease-suscep
ndicates neither virions nor RNC formation.
b CaCl2 method was used to isolate coat protein from density gradi
c Wt BMV genomic RNA transcripts were synthesized in vitro from clo
ubstitutions at position 10 (4/10P), 13 (4/13P), and 14 (4/14P) were tra
d In vitro transcripts of Xenopus RNA (1.5 kb) were obtained from aABLE 2
ssembly Assaysa
RNA transcriptsc
4 4/10P 4/13P 4/14P Xenopus RNAd
V V V —
C RNC RNC RNC —
C RNC RNC RNC —
C RNC RNC RNC —
V V V —
al. (1995) and examined under EM. V, presence of icosahedral virions; RNC
tible RNC was formed as evidenced by agarose gel electrophoresis; (—)
ent-purified virus preparations.
ned cDNA (Dreher et al., 1989). In vitro transcripts of wt RNA4 or with prolinegarose gel electrophoresis. A distinctive radioactive
and was detected for each untreated control sample
C
tFIG. 4. (A) In vitro reassembly assays. Electron micrographic images
showing the negatively stained preparations of in vitro reassembled par-
ticles from purified CP of either wt BMV or a proline variant and the
indicated wt BMV RNAs. Bar 5 100 nm. (B) Northern blot analysis of RNA
solated from in vitro reassembled virions. Conditions for denaturation of
NA, electrophoresis, and hybridization with riboprobes are as described
or Fig. 3B. Each blot was hybridized with a riboprobe complementary to
P sequence. The position of BMV RNAs 3 and 4 is shown to the left and
he position of all four BMV RNAs is shown to the right.
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213SELECTIVE PACKAGING OF BMV RNA4(but not in RNase-treated sample) and their migration
was similar to that of a complex formed between wt CP
and RNA4 transcripts (Table 2). No such complex forma-
tion was observed between wt and mutant CP and Xe-
nopus RNA even in untreated samples, demonstrating
that, under the condition tested, the interaction between
BMV CP and RNA is highly specific (Table 2; Choi et al.,
000). These observations suggest that CP subunits with
-terminal proline mutations did not abolish interactions
ith RNA4 but interfered with virion assembly.
utations in CP, not its mRNA, are responsible for
he defective packaging
Our in vivo infectivity and in vitro reassembly experi-
ments (Figs. 3F and 4A) demonstrated that mature BMV
CPs having proline substitutions in the ARM at positions
10, 13, and 14 are specifically defective in packaging
RNA4. However, a possibility exists that the defective
packaging of RNA4 could have been due to a change in
RNA sequence and/or its structure by the engineered
base substitutions. To verify this possibility, mutations
specifying 10P, 13P, 14P, and 18P were independently
engineered into a CP ORF sequence of pT7B4 (Choi et
al., 2000; a plasmid from which RNA4 transcripts similar
to those found in wt BMV virions can be transcribed in
vitro using T7 RNA polymerase). Wt and each mutant
RNA4 transcript was allowed to interact with wt CP and
reassemble into virions in vitro. Irrespective of the RNA4
transcript, icosahedral virions with a morphology indis-
tinguishable from those of wt BMV were obtained in each
FIG. 5. (A) Schematic diagram showing the location of alanine and l
alanine or lysine substitutions (for e.g., B3/10A and B3/10K, Arg-10 rep
by an underline. (B) Virion RNA profiles of B3 CP variants bearing alanin
virions purified from C. quinoa leaves infected with either wt BMV (wt)
ig. 3F. The positions of the four wild-type BMV RNAs are shown to thassay (Table 2). These observations clearly demonstrate
that selective packaging defects of RNA4 by variant CPs10P, 13P, and 14P are due to engineered changes in the
amino acid residue and not in the corresponding RNA
sequences.
Positively charged amino acids at positions 10, 13, or
14 are necessary for RNA4 packaging
To examine whether the defective RNA4 packaging
observed for variant CPs 10P, 13P, and 14P is due to a
lack of a positively charged residue at these locations,
three additional sets of B3 variants were constructed. In
the first two sets, alanine and lysine residues were
substituted for each arginine residue located at positions
10, 13, and 14 (Fig. 5A). A third set of variants was
designed such that two consecutive arginine residues
were replaced either with alanine or lysine residues (Fig.
5A). Inoculation of each set of B3 variants to C. quinoa
resulted in infection phenotypes. Virions could be puri-
fied from symptomatic leaves for each variant and RNA
recovered from these purified virions contained RNA4
but at varying levels (Fig. 5B). No preference for a spe-
cific positively charged residue at locations 10, 13, and
14 was observed since packaging competence of vari-
ants having lysine for arginine was indistinguishable
from wt (Figs. 5B and 5C). However, the significance of
having a positively charged amino acid at positions 10,
13, and 14 was evident from the comparative packaging
efficiency of RNA4 by variants having either alanine or
lysine residues at these locations (i.e., 10A, 13A, and 14A;
10K, 13K, 14K, 13AA14; 13KK14; Figs. 5B and 5C). In
addition, alanine substitutions at these locations also
ubstitutions. The first 25 N-terminal sequences of B3 CP variants with
y alanine and lysine, respectively) for arginine residues are indicated
lysine substitutions. Agarose gel electrophoresis of RNA isolated from
ated B3 CP variants. Conditions of RNA analysis are as described for
.ysine s
laced b
e andhad a detectable effect on the levels of packaged RNA1
(Figs. 5B and 5C). We previously demonstrated that viri-
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214 CHOI AND RAOons recovered from B3/D919 (a variant harboring a dele-
tion of the entire ARM) contained only trace amounts of
RNA1. This reduction in virion RNA1 was subsequently
shown not to be a packaging defect but due to the
stability of virions containing exclusively RNA1 (Choi et
al., 2000). Thus, we offer the same explanation for the
reduced levels of packaged RNA1 for alanine variants
examined in this study. Substitution of either alanine or
lysine for two consecutive arginines located at positions
18 and 19 (i.e., 18AA19 and 18KK19) has no detectable
effect on packaging of all four BMV RNAs (Fig. 5C).
DISCUSSION
A previous two-dimensional proton NMR study using
the first 25 N-terminal amino acids of a bromovirus
showed that this region adopts an a-helical conforma-
tion after RNA binding and such a conformation is due to
the presence of ARM located between amino acids 9 and
19 (van der Graaf et al., 1992); however, they did not
examine the critical amino acids involved in such con-
formation. By comparing the a-helical propensities of wt
and mutant peptides encompassing the ARM of BMV CP,
this study has identified a critical residue within the ARM
required for the peptide to assume a-helical conforma-
ion in solution. The N-terminal region of CCMV CP is
resent as a random coil in solution and assumes a-he-
lical conformation upon RNA binding (van der Graaf et
al., 1992). Although we did not perform the a-helical
content of the mutant peptides in the presence of RNA,
our data suggest that having a proline at position 18 has
a negative effect on the a-helical conformation of the
eptide in solution while similar substitutions at residues
and 10 do not. However, a natural precedence in
upport for the dispensability of a-helical conformation
for CP with arginine-rich RNA-binding motifs can also be
found among members of two cucumoviruses, CMV and
TAV (Rao and Garntham, 1996). CMV and TAV are struc-
turally and genetically very similar to bromoviruses
(Wikoff et al., 1997). The N-terminal arms of CMV and TAV
CPs are also basic due to the high density of arginine
residues and predicted to be important for protein-RNA
interactions (Wikoff et al., 1997). However, this region
cannot adopt an a-helix since it inherently contains two
proline residues (Fig. 1; Wikoff et al., 1997). These obser-
vations support the suggestion of Tan and Frankel (1995)
that while an arginine-rich a-helix may be common, the
rginine-rich motif is structurally versatile. However, be-
ause of the differential effects observed in vivo for these
roline mutations, at least for BMV, the results of in vitro
inding assays appear not to reflect the situation in vivo
Figs. 3 and 4). This could be perhaps due to conforma-
ional differences between shorter peptides and full-
ength proteins.We recently observed that a precise deletion of ARM
rom BMV CP exclusively affected RNA4 packaging (Choi
m
at al., 2000). By examining the biological activity in vivo of
ariants designed to disrupt the N-terminal a-helix, we
identified that a single amino acid contained within the
ARM is crucial for specific interaction with RNA4 and
mediates its packaging. BMV CP variants 10P, 13P, and
14P with a-helices similar to wt exhibited selective de-
ects in packaging RNA4. Where as 18P, the only muta-
ion that disrupted the a-helical conformation in solution,
did not show any affect on packaging BMV RNAs in vitro
and in vivo (Fig. 3F). Additional mutational analysis of
RM revealed that the defective packaging of 10P, 13P,
nd 14P is modulated by the presence of a charged
mino acid at these positions, since BMV RNA3 variants
aving alanine substitutions at these locations also ex-
ibited packaging defects for RNA4 (Figs. 5B and 5C).
he fact that the three genomic and a single subgenomic
NA4 of BMV are packaged into three individual parti-
les suggests viral CP exhibits a high degree of speci-
icity in discriminating not only homologous RNAs from
eterologous RNAs of the host but also each viral RNA
Choi et al., 2000; Cuillel et al., 1983; Osman et al., 1998).
lthough the mechanism behind packaging RNA4 (either
ndependently or along with genomic RNA3) is not fully
nderstood, the observed packaging defects of RNA4 in
his study could be attributed to the inability of the mutant
-terminal arm to recognize a signal in the RNA4 se-
uence that might be necessary for virion assembly. This
ecognizing signal could be different for the other three
MV genomic RNAs. Alternatively it is also possible that
table virions containing RNA4 require correct position-
ng of RNA4 inside the capsid by its interaction with the
-terminal basic arm and that this optimal positioning is
ffected by the absence of positively charged residues at
osition 10, 13, or 14 (Fig. 3F). Taken together our obser-
ations suggest that the mechanism of RNA4 packaging
y BMV CP is distinct from that of BMV genomic RNAs.
In BMV, the rationale for predicting that one molecule
ach of RNA3 and 4 is copacked into particles is either:
i) to stabilize the virions or (ii) there may be a common
ackaging signal since the entire sequence of RNA4 is
ontained within the 39 half of genomic RNA3. However,
ur recent in vitro reassembly experiments revealed that
tability of virions containing either RNA3 or RNA4 is
ndistinguishable from those expected to contain both
NAs. In a similar analysis, we also found that a signal
or efficient RNA3 packaging is localized in the MP ORF
ut not in CP ORF (Y. G. Choi and A. L. N. Rao, manu-
cript in preparation). These observations together with
he data presented here suggest that the packaging
echanism for RNA4 could be distinct from its progeni-
or genomic RNA3 and likely to be modulated by se-
uence and/or structural features dictated by each RNA
nd the CP.
The mechanism of RNA packaging in multicomponent
embers of Bromoviridae is not fully understood. In
lfamoviruses, the independent packaging of RNA4 is
K
m c
(
E
i
u
o
w
p
C
a
d
a
215SELECTIVE PACKAGING OF BMV RNA4obvious because of the particle heterogeneity (Bol and
Jaspars, 1994). By contrast, bromo and cucumoviruses do
not exhibit any particle heterogeneity and therefore
RNA4 is believed to be copackaged with genomic RNA3.
However, earlier density gradient studies involving the
characterization of the multicomponent nature of BMV
revealed the possible existence of a fourth component
containing exclusively RNA4 molecules (Brakke, 1971;
Herzog and Hirth, 1978). Recent examination of BMV
assembly in a yeast system revealed that, unlike in
poliovirus (Nugent et al., 1999), packaging of BMV is
independent of viral replication and a genetically engi-
neered BMV RNA4 has been found to be packaged
independently into a 120-subunit capsids (Krol et al.,
1999). These studies together with the specific packag-
ing defects observed for RNA4 in this study suggest the
existence of a fourth component selectively containing
only RNA4.
MATERIALS AND METHODS
Synthetic peptides, RNA binding assays, and circular
dichroism
Peptides were synthesized and characterized as de-
scribed by Chen and Frankel (1994). Each peptide termi-
nus was blocked with amino-terminal succinyl and car-
boxyl-terminal amide groups to help stabilize possible
helical conformations. For RNA-binding assays, a de-
sired concentration of a peptide and radiolabeled RNA
transcript were incubated together for 15 min on ice in a
10-ml binding reaction mixture containing 10 mM Hepes/
OH (pH 7.5), 100 mM KCl, 1 mM MgCl2, 0.5 mM EDTA, 1
M DTT with or without 50 mg Escherichia coli tRNA, 50
mg heparin, and 10% (vol/vol) glycerol. Free RNAs and
peptide-RNA complexes were resolved on 1% agarose
gel as described by Duggal and Hall (1993). CD spectra
were measured with an Jasco Model J-600 CD spec-
tropolarimeter. Samples were prepared in 10 mM potas-
sium phosphate (pH 7.5) and 100 mM KF, and tempera-
ture was maintained at 4°C. a-Helical content was de-
termined according to Tan et al. (1993).
Plasmid constructs
All coat protein mutants constructed in this study are
derived from a plasmid, pT7B3, which contains a cDNA
clone of full-length wild-type BMV RNA3 (wt B3; Dreher et
al., 1989). Using PCR and a desired combination of a 59
mutagenic oligonucleotide primer and a common 39
primer, several B3 variant clones were constructed to
contain specific amino acid substitutions within the
N-terminal ARM of BMV CP (Choi et al., 2000). Each PCR
product was digested with SalI (located at 1253) and StuI
(located 1781) and subcloned into similarly treated
pT7B3. The nucleotide sequence of the subcloned frag-
ments was determined to verify the presence of the
expected mutations.In vitro transcription, transfection of protoplasts, RNA,
and coat protein analysis
Full-length cDNA clones corresponding to the three
genomic RNAs of BMV, pT7B1, pT7B2, and pT7B3, from
which infectious RNAs can be transcribed in vitro, have
been described previously (Dreher et al., 1989). Con-
struction of pT7B4, from which RNA4 transcripts identical
to that found in wt BMV can be synthesized in vitro, has
been described previously (Choi et al., 2000). All wt and
variant clones were linearized with BamHI prior to tran-
scription. Capped full-length transcripts were synthe-
sized in vitro using a MEGAscript T7 kit (Ambion Inc.,
Austin, TX). Unless specified otherwise, B3 variant tran-
scripts were always coinoculated with those of wt B1
and B2. Control inoculations always contained in vitro
transcripts of all three wt BMV transcripts. Isolation and
transfection of barley (Hordeum vulgare cv. Dickson) pro-
toplasts and procedures used to extract progeny RNA
and their analysis by Northern hybridization using ribo-
probes corresponding to the 39 conserved region were
performed as described by Rao and Grantham (1995). For
CP analysis, samples were suspended in Laemmli’s
sample buffer and proteins were fractionated on a 16%
SDS-PAGE. Following electrotransfer to nitrocellulose
membrane, CP was detected using anti-BMV CP and a
chemiluminescent kit (Amersham Pharmacia Biotech,
Piscataway, NJ).
Biological assays and virus purification
C. quinoa plants were kept in the dark for at least 18 h
and were mechanically inoculated with 10 ml of a mixture
ontaining viral RNA transcripts in desired combinations
150 mg/ml) as previously described (Rao et al., 1994).
ach experiment was repeated at least three times with
ndependently synthesized in vitro transcripts. The inoc-
lated plants were kept in the greenhouse at 25°C and
bserved for symptom expression over a period of 2–3
eeks. Methods of virus purification and RNA extraction
rocedures were according to Rao et al. (1994).
oat protein preparation, in vitro reassembly assays,
nd electron microscopy
Purified BMV virions of either wt or variants were
issociated into CP by dialyzing at 4°C for 24 h against
buffer containing 500 mM CaCl2, 50 mM Tris-HCl, pH
7.5, 1 mM EDTA, 1 mM DTT, and 0.5 mM PMSF. Fol-
lowing a low-speed centrifugation at 12,000 g for 30
min, the supernatant was subjected to 155,000 g for
2 h to remove intact virions. Dissociated coat protein
concentration was determined by a spectrophotome-
ter. For in vitro reassembly assays, CP and desired
RNA transcripts were mixed in ratio of 1:5 (wt/wt) and
dialyzed at 4°C for 24 h against an assembly buffer
containing 50 mM NaCl, 50 mM Tris-HCl, pH 7.2, 10
v
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216 CHOI AND RAOmM KCl, 5 mM MgCl2, and 1 mM DTT. The assembled
irions were concentrated using Centricon-100 mi-
roconcentrators (Amicon, Beverly, MA). In vitro reas-
embled virions were negatively stained with 1% ura-
yl acetate and examined under an Hitachi transmis-
ion electron microscope.
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